Sunil Healthcare Ltd
Incorporated in 1976, Sunil Healthcare Ltd is a manufacturer of Empty Hard Gelatin, HPMC Capsule Shells & Ayurvedic Medicines[1]
- Market Cap ₹ 71.6 Cr.
- Current Price ₹ 69.8
- High / Low ₹ 104 / 60.6
- Stock P/E
- Book Value ₹ 72.0
- Dividend Yield 0.00 %
- ROCE 2.57 %
- ROE -2.86 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.97 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 2.08% over past five years.
- Company has a low return on equity of 6.60% over last 3 years.
- Company has high debtors of 192 days.
- Working capital days have increased from 128 days to 217 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Miscellaneous
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
46.14 | 61.66 | 72.64 | 81.63 | 108.95 | 90.22 | 80.93 | 70.13 | 89.89 | 116.37 | 111.83 | 89.69 | 83.53 | |
38.36 | 50.35 | 60.57 | 66.75 | 93.21 | 75.52 | 68.45 | 76.58 | 83.68 | 98.55 | 92.52 | 85.24 | 71.90 | |
Operating Profit | 7.78 | 11.31 | 12.07 | 14.88 | 15.74 | 14.70 | 12.48 | -6.45 | 6.21 | 17.82 | 19.31 | 4.45 | 11.63 |
OPM % | 16.86% | 18.34% | 16.62% | 18.23% | 14.45% | 16.29% | 15.42% | -9.20% | 6.91% | 15.31% | 17.27% | 4.96% | 13.92% |
1.33 | 0.38 | 0.94 | 1.33 | 1.25 | 2.00 | 0.09 | 14.71 | 5.56 | 1.55 | 1.63 | 4.53 | 1.41 | |
Interest | 3.10 | 2.48 | 2.85 | 4.36 | 4.18 | 5.03 | 6.58 | 6.95 | 5.31 | 3.49 | 4.17 | 5.78 | 6.66 |
Depreciation | 3.82 | 4.09 | 4.00 | 3.82 | 4.33 | 4.78 | 5.74 | 6.13 | 6.11 | 6.31 | 7.01 | 6.08 | 6.11 |
Profit before tax | 2.19 | 5.12 | 6.16 | 8.03 | 8.48 | 6.89 | 0.25 | -4.82 | 0.35 | 9.57 | 9.76 | -2.88 | 0.27 |
Tax % | 33.79% | 35.94% | 35.39% | 34.99% | 33.73% | 22.64% | 28.00% | -13.49% | 22.86% | 29.15% | 28.48% | -27.08% | |
1.44 | 3.28 | 3.98 | 5.23 | 5.62 | 5.32 | 0.18 | -4.17 | 0.28 | 6.78 | 6.98 | -2.11 | -0.01 | |
EPS in Rs | 1.40 | 3.20 | 3.88 | 5.10 | 5.48 | 5.19 | 0.18 | -4.07 | 0.27 | 6.61 | 6.81 | -2.06 | -0.01 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 4% |
5 Years: | 2% |
3 Years: | 0% |
TTM: | -6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | 100% |
Stock Price CAGR | |
---|---|
10 Years: | 5% |
5 Years: | 31% |
3 Years: | 1% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 6% |
5 Years: | 3% |
3 Years: | 7% |
Last Year: | -3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 | 10.25 |
Reserves | 9.60 | 12.87 | 15.62 | 20.81 | 33.24 | 38.54 | 38.88 | 37.52 | 37.82 | 44.53 | 51.47 | 63.79 | 63.58 |
22.45 | 19.94 | 25.16 | 37.06 | 44.53 | 60.62 | 55.08 | 49.45 | 49.82 | 34.68 | 36.79 | 66.15 | 61.63 | |
11.05 | 12.59 | 12.51 | 17.66 | 31.33 | 33.18 | 35.50 | 37.19 | 25.68 | 22.73 | 27.57 | 23.70 | 29.41 | |
Total Liabilities | 53.35 | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 163.89 | 164.87 |
27.47 | 27.02 | 27.31 | 40.94 | 59.72 | 70.92 | 68.82 | 69.97 | 69.80 | 69.97 | 70.43 | 87.16 | 95.49 | |
CWIP | 1.25 | 0.26 | 0.77 | 0.06 | 0.12 | 0.19 | 2.47 | 0.01 | 0.01 | 1.75 | 0.01 | 5.66 | 0.02 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.24 | 0.24 | 1.20 | 1.16 | 0.00 | 0.00 | 0.00 |
24.63 | 28.37 | 35.46 | 44.78 | 59.51 | 71.25 | 68.18 | 64.19 | 52.56 | 39.31 | 55.64 | 71.07 | 69.36 | |
Total Assets | 53.35 | 55.65 | 63.54 | 85.78 | 119.35 | 142.59 | 139.71 | 134.41 | 123.57 | 112.19 | 126.08 | 163.89 | 164.87 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
4.24 | 8.18 | 5.88 | 7.77 | 10.79 | 4.91 | 15.07 | 4.18 | 16.63 | 21.89 | 7.13 | -14.35 | |
-7.64 | -2.72 | -8.48 | -14.90 | -12.85 | -17.36 | -3.08 | -2.46 | -11.33 | -3.35 | -3.40 | -10.62 | |
3.12 | -5.00 | 2.75 | 8.18 | 2.23 | 11.62 | -11.66 | -1.54 | -6.42 | -18.56 | -3.75 | 25.00 | |
Net Cash Flow | -0.28 | 0.46 | 0.15 | 1.05 | 0.17 | -0.83 | 0.33 | 0.18 | -1.12 | -0.01 | -0.02 | 0.04 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 111.38 | 100.04 | 99.39 | 107.94 | 130.49 | 194.11 | 186.63 | 149.01 | 112.84 | 69.00 | 115.90 | 192.37 |
Inventory Days | 198.13 | 132.12 | 109.32 | 134.28 | 74.03 | 98.26 | 185.09 | 283.19 | 95.96 | 76.84 | 97.03 | 98.42 |
Days Payable | 147.76 | 107.06 | 80.62 | 106.03 | 137.66 | 180.38 | 280.22 | 297.33 | 107.97 | 64.07 | 112.06 | 44.74 |
Cash Conversion Cycle | 161.75 | 125.10 | 128.09 | 136.18 | 66.86 | 111.99 | 91.50 | 134.87 | 100.83 | 81.77 | 100.87 | 246.04 |
Working Capital Days | 102.36 | 87.31 | 92.56 | 104.90 | 82.72 | 145.08 | 136.38 | 122.10 | 103.95 | 63.08 | 104.31 | 216.99 |
ROCE % | 12.44% | 18.13% | 19.19% | 20.80% | 16.37% | 12.08% | 6.39% | 2.38% | 5.84% | 13.88% | 14.73% | 2.57% |
Documents
Announcements
-
Compliance Certificate As per Regulation 40(10) Of SEBI (LODR) Regulations, 2015 For Year Ended 31.03.2025
16 Apr - Annual compliance certificate for timely share transfers issued.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr
- Closure of Trading Window 27 Mar
-
Announcement under Regulation 30 (LODR)-Change in Directorate
25 Mar - Approval of remuneration and appointment of directors.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
25 Mar - Voting results for postal ballot and director appointments.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Concalls
-
Nov 2018TranscriptNotesPPT
-
Sep 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Dec 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
May 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Nov 2016TranscriptNotesPPT
-
Aug 2016TranscriptNotesPPT
-
May 2016TranscriptNotesPPT
-
Mar 2016TranscriptNotesPPT
Business Overview:[1]
Company is the second-largest manufacturer of Empty Hard Shell Gelatin Capsules in India which its sells under the brand name Sunloc. Company does production of double lock, triple lock, multiple groove capsules of EHGC & some proportion of vegan HPMC (Hydroxy Propyl Methyl Cellulose) along with liner, circular, two color printing & 360degree printing being offered